Polypure has signed a five-year contract to supply BD Biosciences with specialist PEGs for its existing and in-development diagnostic ranges.
BD is the latest medical technology company to recognise the advantages of Polypure's monodisperse products.
Magali Le Bomin, marketing director at Polypure, said: 'The polymer homogeneity achieved by using our sample displacement chromatographic purification method ensures a high level of functional integrity.
'Likewise, the single molecular weight avoids the characterisation problems of usual polymer mixtures.
'In diagnostics we can significantly improve cross-linking, binding and lot-to-lots reproducibility.
'Furthermore, there is the overriding benefit of being able to reduce diagnostic complexity which has a significant impact on development, regulatory and production times.'
